← FDA DRUG APPROVALS

FDA NDA · NDA210331

YUTIQ

fluocinolone acetonide

Sponsor: ALIMERA SCIENCES INC

APPLICATION
NDA210331
TYPE
NDA
ORIGINAL APPROVAL
2018-10-12
LATEST ACTION
2018-10-12
ROUTE
INTRAVITREAL
DOSAGE FORM
IMPLANT
MARKETING STATUS
Prescription

Products

YUTIQ · ReferencePrescription
FLUOCINOLONE ACETONIDE 0.18MG · IMPLANT · INTRAVITREAL

Approval history

2018-10-12Type 5 - New Formulation or New Manufacturer · Original · standard — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →